サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1562194

アジア太平洋PCR技術：2030年市場予測-地域別分析-技術、製品、用途、エンドユーザー別

Asia Pacific PCR Technologies Market Forecast to 2030 - Regional Analysis - by Technology, Offerings, Application, and End User

出版日
ページ情報
英文 148 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
アジア太平洋PCR技術：2030年市場予測-地域別分析-技術、製品、用途、エンドユーザー別
出版日: 2024年07月04日
発行: The Insight Partners
ページ情報: 英文 148 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋PCR技術市場は、2022年の28億3,520万米ドルから2030年には54億6,560万米ドルに成長すると予測されています。2022年から2030年までのCAGRは8.6%を記録すると推定されます。

PCR技術への投資急増と資金確保がアジア太平洋PCR技術市場を後押し

2023年、世界中の政府および連邦機関は、ゲノムベースの研究における定量ポリメラーゼ連鎖反応（qPCR）およびデジタルPCR（dPCR）製品の役割を認識しています。RNA技術の主要なイノベーターであるMirxes社は、特にがんなどの早期疾患検出のための正確で非侵襲的、かつリーズナブルな価格の血液ベースのmiRNA検査キットを専門としており、シリーズD資金調達ラウンドで5,000万米ドルを調達しました。同社の主要製品であるGASTROClearは、胃がんを早期に発見するためのPCRを用いた体外診断検査です。米国FDAからブレークスルー・デバイスに指定されています。米国FDAがこのような分類を与えたのは、胃がんの早期診断のための体外診断用医薬品検査、東南アジアの分子体外診断用医薬品検査、血液中のmiRNA検査が世界初です。また、遺伝子合成の強化のために研究開発資金を増やしている企業もあります。2022年、Temasekはインドにあるヘルステック事業Molbio Diagnosticsに8,500万米ドルを拠出しました。Molbioは、HIV、デング熱、マラリア、肝炎、結核など、さまざまな疾患の携帯型診断ツールを設計しています。2021年、シリーズE+の資金調達ラウンドで、分子診断ツールを開発する中国のPOC（ポイント・オブ・ケア）企業であるUstarは、およそ260万米ドルを調達しました。Ustarは調達資金の一部を、主力製品であるハイスループット完全自動核酸増幅検査装置の有効性を向上させるために使用します。残りの資金は、次世代検査プラットフォームの開発、提供する検査の種類の増加、家庭用ポリメラーゼ連鎖反応（PCR）検査キットの大量生産に充てられます。

したがって、疾患特異的ゲノミクスの研究開発に対する財政支援の利用可能性が高まっていることが、PCR技術の需要を促進しています。

アジア太平洋PCR技術市場概要

アジア太平洋PCR技術市場は、中国、日本、インド、韓国、オーストラリア、その他アジア太平洋地域に区分されます。アジア太平洋における市場成長の主な要因は、外国直接投資の増加、高度に熟練した効率的な労働力の大規模な利用可能性、バイオテクノロジー分野への高投資をもたらす政府政策の合理化です。加えて、感染症や慢性疾患の増加、政府や非政府の取り組みがアジア太平洋におけるPCR技術市場の成長を後押ししています。予測期間中の中国におけるPCR技術市場の予測成長は、高品質のヘルスケア製品に対する需要の増加、同国における生活習慣病の有病率の増加、診断技術の新興諸国開拓、診断センターや病院の急増、病院における医療施設の近代化の進行に起因しています。中国では、PCR技術は着床前遺伝子診断（PGD）、がん治療、非侵襲的出生前検査（NIPT）に使用されています。2023年2月に発表された記事「希少疾患の日：なぜ中国の希少疾患負担はイノベーションの機会になり得るのか」によると、～2,000万人の中国人が希少疾患に苦しんでいます。dPCRやqPCRのようなPCR技術は、そのような希少疾患の診断や治療（治療効果のモニタリング）に使用することができます。中国におけるがんの有病率の上昇もPCR技術市場の成長に寄与しています。Global Cancer Observatoryのデータによると、中国では2020年に460万人のがん患者が報告されました。また、中国ではがんにより310万人が死亡しています。中国PCR技術市場の収益と2030年までの予測（百万米ドル）金額で見ると、中国のPCR技術市場は2022年に7億7,623万米ドルと評価され、2030年には15億4,521万米ドルに達すると予測され、予測期間中のCAGRは9.00%と予測されます。

アジア太平洋PCR技術市場の収益と2030年までの予測（金額）

アジア太平洋PCR技術市場のセグメンテーション

アジア太平洋PCR技術市場は、技術、製品、用途、エンドユーザー、国にセグメント化されます。

技術に基づき、アジア太平洋PCR技術市場はリアルタイムPCR、コンベンショナルPCR、逆転写、デジタルPCR、マルチプレックスRTPCR、ホットスタートPCR、その他に区分されます。リアルタイムPCRセグメントは2022年にアジア太平洋PCR技術市場で最大のシェアを占めました。

製品の観点から、アジア太平洋PCR技術市場は試薬・消耗品、機器、ソフトウェア・サービスにセグメント化されます。試薬・消耗品セグメントは2022年にアジア太平洋PCR技術市場で最大のシェアを占めました。さらに、試薬・消耗品セグメントは試薬、バイアルサイズ、その他の消耗品に分類されます。さらに、バイアルサイズは0.2ml～2ml、0.1ml～0.3ml、2ml～5ml、その他のバイアルに区分されます。さらに、機器セグメントはベンチトップPCRとポータブルサーモサイクラー/PCRに二分されます。

用途別では、アジア太平洋PCR技術市場は、遺伝子発現解析、遺伝子配列決定、ジェノタイピング、核酸合成、標準バリデーション、ポイントオブケア診断用途、環境用途、その他に区分されます。遺伝子発現解析セグメントは、2022年にアジア太平洋PCR技術市場で最大のシェアを占めました。

エンドユーザーに基づき、アジア太平洋PCR技術市場は病院・診断センター、製薬・バイオテクノロジー企業、学術機関・研究所、その他に区分されます。病院・診断センターセグメントが2022年のアジア太平洋PCR技術市場で最大のシェアを占めました。

国別では、アジア太平洋PCR技術市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に分類されています。中国は2022年にアジア太平洋PCR技術市場を独占しました。

Thermo Fisher Scientific Inc、Promega Corp、QIAGEN NV、bioMerieux SA、Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Becton Dickinson and Co、Takara Bio Inc、Standard Bio Tools Inc、Agilent Technologies Inc、Ellume Ltdは、アジア太平洋PCR技術市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋PCR技術市場- 主要産業力学

  • PCR技術市場- 主要産業力学
  • 市場促進要因
    • 遺伝病および感染症の流行増加
    • PCR技術への投資と資金調達の急増
  • 市場抑制要因
    • PCRシステムの高コストと代替アッセイの利用可能性
  • 市場機会
    • 新興国におけるPCR技術の採用増加
    • POC検査に対する需要の増加
  • 今後の動向
    • PCR技術の進歩
  • 促進要因と抑制要因の影響

第5章 アジア太平洋PCR技術市場：市場分析

  • PCR技術の市場収益、2020年～2030年

第6章 アジア太平洋PCR技術市場分析：技術別

  • リアルタイムPCR
  • コンベンショナルPCR
  • 逆転写PCR
  • デジタルPCR
  • マルチプレックスRT PCR
  • ホットスタートPCR
  • その他

第7章 アジア太平洋PCR技術市場分析：製品別

  • PCR技術市場：収益シェア、製品別、2022年・2030年（%）
  • 試薬・消耗品
  • 機器
  • ソフトウェアとサービス

第8章 アジア太平洋PCR技術市場分析：用途別

  • PCR技術市場：収益シェア、用途別、2022年・2030年（%）
  • 遺伝子発現解析
  • 遺伝子配列決定
  • ジェノタイピング
  • 核酸合成
  • 標準バリデーション
  • ポイントオブケア診断
  • 環境用途
  • その他

第9章 アジア太平洋PCR技術市場分析：エンドユーザー別

  • PCR技術市場：収益シェア、エンドユーザー別、2022年・2030年（%）
  • 病院および診断センター
  • 学術機関および研究機関
  • 製薬・バイオテクノロジー企業
  • その他

第10章 アジア太平洋PCR技術市場：国別分析

  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域

第11章 PCR技術市場-業界情勢

  • PCR技術市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • QIAGEN NV
  • bioMerieux SA
  • Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Becton Dickinson and Co
  • Takara Bio Inc
  • Standard Biotools Inc
  • Agilent Technologies Inc
  • Ellume Ltd

第13章 付録

図表

List Of Tables

  • Table 1. PCR Technologies Market Segmentation
  • Table 2. PCR Technologies Market - Revenue and Forecast to 2030 (US$ Million) - By Technology
  • Table 3. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Offerings
  • Table 4. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
  • Table 5. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • Table 6. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • Table 7. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Application
  • Table 8. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By End User
  • Table 9. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 10. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 11. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 12. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 13. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 14. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 15. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 16. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 17. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 18. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 19. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 20. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 21. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 22. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 23. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 24. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 25. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 26. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 27. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 28. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 29. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 30. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 31. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 32. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 33. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 34. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 35. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 36. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 37. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 38. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 39. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 40. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 41. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 42. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 43. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 44. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 45. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 46. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 47. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 48. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 49. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 50. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 51. Recent Inorganic Growth Strategies in the PCR Technologies Market
  • Table 52. Recent Organic Growth Strategies in the PCR Technologies Market
  • Table 53. Glossary of Terms, PCR Technologies Market

List Of Figures

  • Figure 1. PCR Technologies Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. PCR Technologies Market Share (%) - By Technology, 2022 and 2030
  • Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. PCR Technologies Market Share (%) - By Offerings, 2022 and 2030
  • Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 16. PCR Technologies Market Share (%) - By Application, 2022 and 2030
  • Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 25. PCR Technologies Market Share (%) - By End User, 2022 and 2030
  • Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 30. Asia Pacific: PCR Technologies Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. Asia Pacific PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 32. China PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 33. Japan PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 34. India PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 35. Australia PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 36. South Korea PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 37. Rest of Asia Pacific PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 38. Growth Strategies in the PCR Technologies Market
目次
Product Code: BMIRE00030379

The Asia Pacific PCR technologies market is expected to grow from US$ 2,835.20 million in 2022 to US$ 5,465.60 million by 2030. It is estimated to record a CAGR of 8.6% from 2022 to 2030.

Surging Investments and Funds Availability for PCR Technologies Boost Asia Pacific PCR Technologies Market

Government and federal agencies worldwide recognize the role of quantitative polymerase chain reaction (qPCR) and dPCR products in genome-based research in 2023, Mirxes, a leading innovator in RNA technology, specializes in accurate, non-invasive, and reasonably priced blood-based miRNA testing kits for early disease detection, particularly cancer, raised US $50 million in a Series D funding round. The company's main offering, GASTROClear, is an in vitro diagnostic test that uses PCR to detect stomach cancer early on. It has been designated as a Breakthrough Device by the US FDA. This is the first time that the US FDA has given such a classification to an IVD test for early diagnosis of stomach cancer, a molecular IVD test from Southeast Asia, and a blood miRNA test worldwide. Some companies have also increased their research and development funds for the enhancement of gene synthesis. In In 2022, Temasek contributed US $85 million to the healthtech business Molbio Diagnostics, located in India. Molbio designs portable diagnostic tools for a range of conditions, including HIV, dengue, malaria, hepatitis, and tuberculosis (TB). In 2021, in a Series E+ fundraising round, Ustar, a Chinese point-of-care (POC) business that creates molecular diagnostic tools, raised roughly US$ 2.6 million. Ustar will use a portion of the funds raised to improve the effectiveness of their flagship high-throughput, completely automated nucleic acid amplification test instrument. The remaining funds will go into developing a next generation testing platform, increasing the variety of tests offered, and mass-producing polymerase chain reaction (PCR) testing kits for home usage.

Therefore, the increasing availability of financial support for research and development in disease-specific genomics propels the demand for PCR technologies.

Asia Pacific PCR Technologies Market Overview

The Asia Pacific PCR technologies market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth in Asia Pacific is mainly attributed to the increasing foreign direct investments; the large availability of highly skilled, efficient workforces; and streamlining government policies resulting in high investments in the biotechnology sector. In addition, increasing cases of infectious and chronic diseases, and government and non-government initiatives fuel the growth of the PCR technologies market in Asia Pacific. The projected growth of the PCR technologies market in China during the forecast period is attributed to the increasing demand for high-quality healthcare products, growing prevalence of lifestyle diseases in the country, rising developments in diagnostics technologies, surging number of diagnostic centers and hospitals, and the ongoing modernization of medical facilities in hospitals. In China, PCR techniques are used for preimplantation genetic diagnosis (PGD), cancer treatment, and noninvasive prenatal testing (NIPT). According to the article "Rare Disease Day: why China's Rare Disease Burden Could Be an Opportunity for Innovation," published in February 2023, ~20 million Chinese people suffer from rare diseases. PCR techniques such as dPCR and qPCR can be used in the diagnosis and treatment (to monitor treatment response) of such rare conditions. The rising prevalence of cancer in China also contributes to the PCR technologies market growth. According to the Global Cancer Observatory data, ~4.6 million cancer cases were reported in the country in 2020. In addition, cancer resulted in the death of 3.1 million people in China. China PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn) In terms of value, the PCR technologies market in China was valued at US$ 776.23 million in 2022 and is projected to reach US$ 1,545.21 million by 2030; it is expected to register a CAGR of 9.00% during the forecast period.

Asia Pacific PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific PCR Technologies Market Segmentation

The Asia Pacific PCR technologies market is segmented into technology, offerings, application, end user, and country.

Based on technology, the Asia Pacific PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held largest share of Asia Pacific PCR technologies market in 2022.

In terms of offerings, the Asia Pacific PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of Asia Pacific PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.

By application, the Asia Pacific PCR technologies market is segmented gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of Asia Pacific PCR technologies market in 2022.

Based on end user, the Asia Pacific PCR technologies market is segmented hospitals & diagnostic centers, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centers segment held the largest share of Asia Pacific PCR technologies market in 2022.

By country, the Asia Pacific PCR technologies market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific PCR technologies market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, and Ellume Ltd are some of the leading companies operating in the Asia Pacific PCR technologies market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific PCR Technologies Market - Key Industry Dynamics

  • 4.1 PCR Technologies Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Genetic and Infectious Diseases
    • 4.2.2 Surging Investments and Funds Availability for PCR Technologies
  • 4.3 Market Restraints
    • 4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
  • 4.4 Market Opportunities
    • 4.4.1 Increasing Adoption of PCR Techniques in Emerging Countries
    • 4.4.2 Increasing Demand for POC Testing
  • 4.5 Future Trends
    • 4.5.1 Advancements in PCR Technologies
  • 4.6 Impact of Drivers and Restraints:

5. PCR Technologies Market - Asia Pacific Market Analysis

  • 5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030

6. Asia Pacific PCR Technologies Market Analysis - By Technology

  • 6.1 Overview
  • 6.2 Real Time PCR
    • 6.2.1 Overview
    • 6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Conventional PCR
    • 6.3.1 Overview
    • 6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Reverse Transcription PCR
    • 6.4.1 Overview
    • 6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Digital PCR
    • 6.5.1 Overview
    • 6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Multiplex RT PCR
    • 6.6.1 Overview
    • 6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Hot Start PCR
    • 6.7.1 Overview
    • 6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific PCR Technologies Market Analysis - By Offerings

  • 7.1 Overview
  • 7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
  • 7.3 Reagents and Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
        • 7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • 7.5 Software and Services
    • 7.5.1 Overview
    • 7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific PCR Technologies Market Analysis - By Application

  • 8.1 Overview
  • 8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Gene Expression Analysis
    • 8.3.1 Overview
    • 8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Genetic Sequencing
    • 8.4.1 Overview
    • 8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Genotyping
    • 8.5.1 Overview
    • 8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Nucleic Acid Synthesis
    • 8.6.1 Overview
    • 8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Standard Validation
    • 8.7.1 Overview
    • 8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Point of Care Diagnostics
    • 8.8.1 Overview
    • 8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Environmental Application
    • 8.9.1 Overview
    • 8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Others
    • 8.10.1 Overview
    • 8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific PCR Technologies Market Analysis - By End User

  • 9.1 Overview
  • 9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Academia and Research Institutes
    • 9.4.1 Overview
    • 9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Pharmaceutical and Biotechnology Companies
    • 9.5.1 Overview
    • 9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific PCR Technologies Market -Country Analysis

  • 10.1 Asia Pacific: PCR Technologies Market
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific PCR Technologies Market Revenue and Forecast and Analysis - By Country
      • 10.1.2.1 China
        • 10.1.2.1.1 Overview
      • 10.1.2.2 China PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.1 China PCR Technologies Market Breakdown by Technology
        • 10.1.2.2.2 China PCR Technologies Market Breakdown by Offerings
        • 10.1.2.2.2.1 China PCR Technologies Market Breakdown by Instruments
        • 10.1.2.2.2.2 China PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.2.2.2.1 China PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.2.3 China PCR Technologies Market Breakdown by Application
        • 10.1.2.2.4 China PCR Technologies Market Breakdown by End User
      • 10.1.2.3 Japan
        • 10.1.2.3.1 Overview
      • 10.1.2.4 Japan PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.4.1 Japan PCR Technologies Market Breakdown by Technology
        • 10.1.2.4.2 Japan PCR Technologies Market Breakdown by Offerings
        • 10.1.2.4.2.1 Japan PCR Technologies Market Breakdown by Instruments
        • 10.1.2.4.2.2 Japan PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.4.2.2.1 Japan PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.4.3 Japan PCR Technologies Market Breakdown by Application
        • 10.1.2.4.4 Japan PCR Technologies Market Breakdown by End User
      • 10.1.2.5 India
        • 10.1.2.5.1 Overview
      • 10.1.2.6 India PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.1 India PCR Technologies Market Breakdown by Technology
        • 10.1.2.6.2 India PCR Technologies Market Breakdown by Offerings
        • 10.1.2.6.2.1 India PCR Technologies Market Breakdown by Instruments
        • 10.1.2.6.2.2 India PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.6.2.2.1 India PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.6.3 India PCR Technologies Market Breakdown by Application
        • 10.1.2.6.4 India PCR Technologies Market Breakdown by End User
      • 10.1.2.7 Australia
        • 10.1.2.7.1 Overview
      • 10.1.2.8 Australia PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.8.1 Australia PCR Technologies Market Breakdown by Technology
        • 10.1.2.8.2 Australia PCR Technologies Market Breakdown by Offerings
        • 10.1.2.8.2.1 Australia PCR Technologies Market Breakdown by Instruments
        • 10.1.2.8.2.2 Australia PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.8.2.2.1 Australia PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.8.3 Australia PCR Technologies Market Breakdown by Application
        • 10.1.2.8.4 Australia PCR Technologies Market Breakdown by End User
      • 10.1.2.9 South Korea
        • 10.1.2.9.1 Overview
      • 10.1.2.10 South Korea PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.10.1 South Korea PCR Technologies Market Breakdown by Technology
        • 10.1.2.10.2 South Korea PCR Technologies Market Breakdown by Offerings
        • 10.1.2.10.2.1 South Korea PCR Technologies Market Breakdown by Instruments
        • 10.1.2.10.2.2 South Korea PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.10.2.2.1 South Korea PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.10.3 South Korea PCR Technologies Market Breakdown by Application
        • 10.1.2.10.4 South Korea PCR Technologies Market Breakdown by End User
      • 10.1.2.11 Rest of Asia Pacific
        • 10.1.2.11.1 Overview
      • 10.1.2.12 Rest of Asia Pacific PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.12.1 Rest of Asia Pacific PCR Technologies Market Breakdown by Technology
        • 10.1.2.12.2 Rest of Asia Pacific PCR Technologies Market Breakdown by Offerings
        • 10.1.2.12.2.1 Rest of Asia Pacific PCR Technologies Market Breakdown by Instruments
        • 10.1.2.12.2.2 Rest of Asia Pacific PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.12.2.2.1 Rest of Asia Pacific PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.12.3 Rest of Asia Pacific PCR Technologies Market Breakdown by Application
        • 10.1.2.12.4 Rest of Asia Pacific PCR Technologies Market Breakdown by End User

11. PCR Technologies Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the PCR Technologies Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Promega Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 QIAGEN NV
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 bioMerieux SA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Hoffmann-La Roche Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Bio-Rad Laboratories Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Becton Dickinson and Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Takara Bio Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Standard Biotools Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Agilent Technologies Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Ellume Ltd
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms